378: How to Build an Alzheimer's-Resistant Brain and Reduce Cognitive Decline | Lisa Mosconi, PhD
The Genius Life
Reduced Risk of Alzheimer's Disease with Estrogen Replacement
Estrogen replacement therapy taken before the final menstrual period or within 10 years after, results in a 32% reduction in the risk of Alzheimer's disease for women with surgical menopause. This reduction in risk was consistent across studies. However, taking estrogen more than 10 years after surgery has no effect on Alzheimer's risk. For women with a uterus, taking estrogen and progesterone for menopause or within 10 years reduces the risk by 23%. Beyond this timeframe, there may be an increased risk. The Women's Health Initiative study plays a significant role in understanding the impact of estrogen replacement therapy on Alzheimer's risk.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
